Cargando…

Closure beyond clozapine: successfully averting rebound symptoms in a patient with schizoaffective disorder and agranulocytosis

SUMMARY: ‘Rebound’ or ‘withdrawal’ symptoms are frequently observed after a sudden discontinuation of clozapine. We describe a patient with treatment-resistant schizoaffective disorder who developed agranulocytosis on clozapine but was successfully switched to treatment with olanzapine with no deter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Green, Alastair, Stephenson, Thomas, Whiskey, Eromona, Shergill, Sukhi S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2019
Materias:	Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537554/ https://www.ncbi.nlm.nih.gov/pubmed/31530315 http://dx.doi.org/10.1192/bjo.2019.31

Ejemplares similares

Successful clozapine rechallenge following recurrent clozapine-associated pancreatitis: a case report
por: Rodriguez, Victoria, et al.
Publicado: (2020)

Distinctive pattern of neutrophil count change in clozapine-associated, life-threatening agranulocytosis
por: Taylor, David, et al.
Publicado: (2022)

Management of clozapine treatment during the COVID-19 pandemic
por: Gee, Siobhan, et al.
Publicado: (2020)

Clozapine haematological monitoring for neutropenia: a global perspective
por: Oloyede, Ebenezer, et al.
Publicado: (2022)

Outcomes in treatment-resistant schizophrenia: symptoms, function and clozapine plasma concentrations
por: Krivoy, Amir, et al.
Publicado: (2021)

Clozapine augmentation with cariprazine for negative symptoms: a case series and literature review
por: Oloyede, Ebenezer, et al.
Publicado: (2022)

Clozapine-induced agranulocytosis
por: Mijovic, Aleksandar, et al.
Publicado: (2020)

Successful clozapine re-challenge in a patient with three previous episodes of clozapine-associated blood dyscrasia
por: Foster, Jessica, et al.
Publicado: (2017)

AGRANULOCYTOSIS DURING CLOZAPINE THERAPY
por: Jagadheesan, K., et al.
Publicado: (2000)

Change in plasma concentration of clozapine and norclozapine following a switch of oral formulation
por: Keshavarzi, Farinaz, et al.
Publicado: (2020)

Late Onset Clozapine Induced Agranulocytosis
por: Velayudhan, Rajmohan, et al.
Publicado: (2014)

The lived experience of clozapine discontinuation in patients and carers following suspected clozapine-induced neutropenia
por: Oloyede, Ebenezer, et al.
Publicado: (2023)

Vortioxetine as adjunctive therapy in the treatment of schizophrenia
por: Redaelli, Sofia, et al.
Publicado: (2022)

Resolution without discontinuation: heart failure during clozapine treatment
por: Whiskey, Eromona, et al.
Publicado: (2020)

CLOZAPINE-INDUCED AGRANULOCYTOSIS AND USE OF G-CSF
por: Srinivasan, T.N., et al.
Publicado: (1998)

Clozapine Pharmacogenetic Studies in Schizophrenia: Efficacy and Agranulocytosis
por: Numata, Shusuke, et al.
Publicado: (2018)

Inflammatory response to clozapine in the absence of myocarditis: case report
por: Davey, Patrick, et al.
Publicado: (2016)

Real-world effectiveness of admissions to a tertiary treatment-resistant psychosis service: 2-year mirror-image study
por: Casetta, Cecilia, et al.
Publicado: (2020)

Possible pharmacogenetic factors in clozapine treatment failure: a case report
por: Whiskey, Eromona, et al.
Publicado: (2021)

Leukopenia and agranulocytosis in atypical antipsychotic treatment - besides clozapine
por: Jorge, B., et al.
Publicado: (2021)

A retrospective case notes review of the effectiveness and tolerability of metoclopramide in the treatment of clozapine-induced hypersalivation (CIH)
por: Livermore, Cecilia, et al.
Publicado: (2022)

Establishing the characteristics of an effective pharmacogenetic test for clozapine-induced agranulocytosis
por: Verbelen, M, et al.
Publicado: (2015)

Pharmacogenomics of Clozapine-induced agranulocytosis: a systematic review and meta-analysis
por: Islam, Farhana, et al.
Publicado: (2022)

Risk of readmission in patients with schizophrenia and schizoaffective disorder newly prescribed clozapine
por: Kesserwani, Jad, et al.
Publicado: (2019)

When the drugs don’t work: treatment-resistant schizophrenia, serotonin and serendipity
por: Lowe, Penelope, et al.
Publicado: (2017)

Clozapine in a patient with treatment-resistant schizophrenia and hypertrophic cardiomyopathy: a case report
por: Sanchez, Asiel Yair Adan, et al.
Publicado: (2016)

Novel use of granulocyte colony stimulating factor as an adjunct for treatment of schizoaffective disorder complicated by sodium valproate induced agranulocytosis
por: Subbarayan, S., et al.
Publicado: (2012)

Loxapine and Cyproheptadine Combined Limit Clozapine Rebound Psychosis and May Also Predict Clozapine Response
por: Aboueid, Lila, et al.
Publicado: (2016)

Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles
por: Goldstein, Jacqueline I, et al.
Publicado: (2014)

Clozapine in a patient with treatment-resistant schizophrenia and hypertrophic cardiomyopathy: a case report — ADDENDUM
por: Sanchez, Asiel Yair Adan, et al.
Publicado: (2019)

Augmentation of Clozapine with Aripiprazole in Severe Psychotic Bipolar and Schizoaffective Disorders: A Pilot Study
por: Benedetti, Alessandra, et al.
Publicado: (2010)

Response after Infection-Associated Rise in Clozapine Levels in Treatment-Resistant Schizoaffective Disorder
por: Grootendorst-van Mil, Nina H., et al.
Publicado: (2018)

Clinical impact of reducing the frequency of clozapine monitoring: controlled mirror-image cohort study
por: Oloyede, Ebenezer, et al.
Publicado: (2023)

Neutropenia and agranulocytosis during treatment of schizophrenia with clozapine versus other antipsychotics: an observational study in Iceland
por: Ingimarsson, Oddur, et al.
Publicado: (2016)

Low-Dose Clozapine-Induced Agranulocytosis in Patients with Movement Disorders—Retrospective Study from India
por: Choudhury, Supriyo, et al.
Publicado: (2021)

The Role of Myeloperoxidase in Clozapine-Induced Inflammation: A Mechanistic Update for Idiosyncratic Drug-Induced Agranulocytosis
por: Sernoskie, Samantha Christine, et al.
Publicado: (2023)

A Case of Sudden Very Late Onset of Severe Clozapine-induced Agranulocytosis Following an Influenza Vaccine
por: Jean, Soluny, et al.
Publicado: (2019)

Considerations of HLA, Renal Failure, Valproic Acid Use, and Current Treatment Guidelines in Clozapine-Induced Agranulocytosis
por: Sussman, Melissa, et al.
Publicado: (2021)

Clozapine rechallenge or continuation despite neutropenia or agranulocytosis using colony-stimulating factor: A systematic review
por: Corbeil, Olivier, et al.
Publicado: (2023)

Agranulocytosis
Publicado: (1945)

Cannot write session to /tmp/vufind_sessions/sess_edt0mto34g3r8uvu1f3jgjf0of